Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sergio Emanuel Kaiser: A Whole New Array of Potent Oral PCSK9 Inhibitors
May 24, 2026, 13:46

Sergio Emanuel Kaiser: A Whole New Array of Potent Oral PCSK9 Inhibitors

Sergio Emanuel Kaiser, Coordinator at UERJ – Discipline of Clinical and Experimental Pathophysiology, Associate Professor of Medicine at Rio de Janeiro State University, shared a post on LinkedIn about a recent article by Rick B. Vega, published in Circulation, adding:

“Exciting!

A whole new array of potent oral PCSK9 inhibitors is underway!

An 80% reduction of LDLc with the highest dose when associated with rosuvastatin 20 mg!”

Title: Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients

Authors: Rick B. Vega, Gavin O’Mahony, April M. Barbour, Hongtao Yu, Jane Knöchel, Johan Brengdahl, Thomas Hochdörfer, Linnéa Bergenholm, Eva Töppner Carlsson, Andrea Ahnmark, Christina Rye Underwood, Anna Rudvik, Debra Carter, Johanna Laru, Aspen Gutgsell, Lee Twaddle, Pavlo Garkaviy, Anna Bogstedt, Eva Hurt-Camejo, Tasso Miliotis, Maria Ryaboshapkina, Andrease Hober, Brian Hubbard, Michael Serrano-Wu, Virendar Kaushik, Stefan Geschwindner, Michael C. McCarthy, Daniel Lindén, Jaya B. Rosenmeier

Sergio Emanuel Kaiser

Stay updated on all scientific advances with Hemostasis Today.